EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”

Chronic Diseases and Translational Medicine · 21.08.2026

DOI: 10.1002/cdt3.70063 ↗

Kurz gefasst

Korrektur in der Zeitschrift Chronic Diseases and Translational Medicine, online erschienen am 21.08.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1002/cdt3.155.].

Zitieren

APA

(2026). Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”. Chronic Diseases and Translational Medicine. https://doi.org/10.1002/cdt3.70063

Vancouver

Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”. Chronic Diseases and Translational Medicine. 2026. doi:10.1002/cdt3.70063

BibTeX
@article{euvimed2026,
  title = {Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2026},
  doi = {10.1002/cdt3.70063}
}
Kostenlos starten →